ClinicalTrials.govpublic full text
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
non-small cell lung cancer, locally advanced or metastatic nsclc, her2 mutations, t-dxd, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842181
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.